Welcome Message:

The International Summit on Haematology and Blood Disorders invites hematologists, physicians, healthcare professionals, researchers, academicians, laboratory specialists, students, pharmaceutical professionals, biotechnologists, and industry experts from around the world to join us in Paris, France.
With the theme “Innovative Approaches and Global Perspectives in Hematology”, the conference will provide a platform to explore recent developments, emerging trends, and innovative approaches in haematology and blood disorders.
The conference will bring experts together to present research, exchange knowledge, discuss advances in diagnosis and treatment, and foster meaningful scientific collaboration.

Why to Join?

Stay informed about the latest trends and developments.
Connect with international experts and researchers
Explore emerging diagnostic and treatment approaches
Present your research and exchange knowledge
Build valuable international collaborations
Opportunity to have accepted abstracts featured in the conference proceedings or associated publication channels
Receive a certificate recognizing your contribution and participation
Enjoy a professional conference experience in Paris, France

Conference Highlights

Scientific Insights — Current research and clinical developments
Expert Sessions — Perspectives from researchers and healthcare professionals
Research Exchange — Presentations and knowledge sharing
Emerging Advances — New approaches in diagnosis and treatment
Professional Networking — Opportunities for collaboration and discussion

Target audience:

Hematologists, Physicians, and Medical Oncologists
Researchers, Clinical Scientists, and Academicians
Pathologists and Laboratory Professionals
Pharmaceutical and Biotechnology Professionals
Nurses and Allied Healthcare Professionals
Students, Research Scholars, and Postdoctoral Fellows
Blood Bank and Transfusion Medicine Professionals
Stem Cell and Cellular Therapy Researchers
Hospital and Industry Professionals
Associations and Research Organizations
Clinical Trial and Drug Development Professionals
Genomics and Molecular Biology Specialists
Healthcare Administrators and Hospital Managers
Medical Technology and Diagnostic Experts
Public Health and Epidemiology Professionals

Scientific Sessions:

Session 1: Hematology and Blood Disorders
Hematology pertains to the study of blood, blood-producing organs, blood components and diseases affecting the hematological system. This session will assess the basic principles and newest achievements in the diagnosis, treatment and study of blood diseases.

Session 2: Advances in Hematology Research
In this session, recent discoveries and advances in hematological research, including laboratory, clinical, translational, and technological breakthroughs in blood disorders management will be presented.

Session 3: Anemia and Red Blood Cell Disorders
Anemia and disorders of red blood cells are some of the most frequent hematological disorders around the globe. This session looks into the causes, diagnosis, ways of preventing the disease, therapy, nutritional aspects, hereditary illnesses, as well as new techniques in patient management.

Session 4: Sickle Cell Disease and Thalassemia
The main topic of discussion for the session is the inherited blood disorders such as sickle cell disease and thalassemia. The session would entail important aspects such as disease mechanisms, diagnosing the disease, advancements in treatment options, supportive care, genetic studies, and therapies in process.

Session 5: Leukemia and Blood Cancers
Leukemia as well as other forms of cancer that affect blood cells are areas that require more research and study. In this session, issues relating to disease biology, diagnosis and risk factors as well as treatment alternatives, targeted therapy and immunotherapy will be discussed.

Session 6: Lymphoma and Multiple Myeloma
This session will discuss advances in the understanding, diagnosis, and treatment of lymphoma and multiple myeloma, including emerging therapies, immunotherapy, targeted treatment, and personalized approaches to care.

Session 7: Hemostasis, Coagulation and Bleeding Disorders
This session will explore the mechanisms that control bleeding and blood clotting, with discussions on hemophilia, coagulation disorders, platelet abnormalities, diagnostic testing, and modern treatment approaches

Session 8: Thrombosis and Blood Clotting Disorders
Thrombosis is an important health concern affecting people across different age groups and medical conditions. This session will address risk factors, diagnosis, prevention, anticoagulation, treatment strategies, and emerging research.

Session 9: Platelets and Blood Cell Function
Platelets and blood cells play essential roles in maintaining normal body functions and protecting against disease. This session will discuss platelet biology, blood cell production, disorders, laboratory testing, and clinical applications.

Session 10: Transfusion Medicine and Blood Banking
Blood transfusion and blood banking are key areas in modern healthcare. In this session, blood donation, blood components, transfusion safety, compatibility testing, blood storage, transfusion reactions, and developments in transfusion medicine will be discussed.

Session 11: Hematopoiesis and Bone Marrow Disorders
There are greater possibilities owing to cellular therapies and stem cell transplants to treat various blood malignancies and diseases. The aim of this session is to elaborate on transplantation, cellular therapies, advancements in treatment, and developments in the future.

Session 12: Stem Cell Transplantation and Cellular Therapy
Stem cell transplantation and cellular therapies are expanding treatment possibilities for several blood disorders and cancers. This session will discuss transplantation, cellular therapies, treatment advances, challenges, and future opportunities.

Session 13: Pediatric Hematology
A child can develop different blood disorders as they need to undergo special diagnosis and treatment procedures. The following issues will be discussed in this session childhood anemia, genetic blood diseases, leukemia, blood shedding disorders as well as blood cancers and breakthroughs in hematology for children.

Session 14: Immunology and Hematology
The connection between the immune system and blood is vital to the understanding of multiple diseases and treatment modalities. In this session, we will discuss disorders involving blood and the immune system, the processes involving immunity, as well as the therapies provided by it, and advances in the field of immunohematology.

Session 15: Molecular Hematology and Genetics
Developments in molecular biology and genetics are enhancing our insight into blood disorders and allowing for more accurate diagnosis and treatment. The meeting will cover genetics, molecular diagnostics, markers, and recently conducted research.

Session 16: Precision Medicine and Personalized Hematology
Modern hematology is increasingly moving toward individualized diagnosis and treatment. This session will explore biomarkers, genetic profiling, targeted therapies, personalized treatment plans, and precision approaches to blood disorders.

Session 17: Innovations in Hematology Diagnostics
Early and accurate diagnosis is essential for effective management of blood disorders. This session will explore advances in laboratory testing, molecular diagnostics, biomarkers, automation, and other technologies supporting modern hematology.

Session 18: Emerging Therapies in Hematology
New therapies are transforming the management of both common and complex blood disorders. This session will discuss targeted therapies, immunotherapy, gene therapy, cellular therapy, novel drugs, and emerging treatment strategies.

Session 19: Artificial Intelligence and Digital Health in Hematology
Digital technologies and artificial intelligence are creating new possibilities for diagnosis, research, monitoring, and personalized healthcare. This session will explore AI applications, digital diagnostics, data analysis, telemedicine, and technology-driven hematology care.

Session 20: Future of Hematology and Blood Disorders
This session will bring together emerging ideas and future perspectives across hematology. Discussions will focus on innovative research, new technologies, evolving treatment strategies, precision medicine, collaborative research, and opportunities shaping the future of blood disorder care.

Visa Assistance
The conference team is pleased to support international participants with their travel preparations. Registered participants who require a visa invitation letter may request the necessary documentation to support their visa application.
Participants are advised to apply well in advance and check the latest requirements with the relevant embassy or consulate. Visa approval is subject to the decision of the respective immigration authorities.
We look forward to welcoming participants from around the world to the International Conference on Hematology and Blood Disorders in Paris, France.

Market Analysis:

The global hematology analyzers & reagents market is expected to grow from USD 7.57 billion in 2026 to USD 10.33 billion by 2031, representing a CAGR of 6.4%. There is a noticeable move towards automation in the hematology analyzers and reagents market. High first-pass yield and auto-validation are two features that have become more desirable in this market segment, as they help reduce repeat analyses and improve productivity. Furthermore, improvements in the design of the analyzers have made it possible to decrease reagent consumption, provide more walk-away time, and reduce manual intervention.
Certain trends and technological developments are reshaping the landscape of hematology analyzers and reagents. There is a clear trend among industry companies towards replacing traditional cell counters with more modern, sophisticated instruments capable of 5- and 6-part differentials, digital morphology, and flow cytometry. Besides, there are new products on the market for reagents and disposables that enable faster processing and increased result accuracy. Furthermore, there is an increase in the adoption of AI technologies, automation, and middleware for analysis by hospitals and laboratories.

Past Conference Report

Previous Hematology and Blood Disorders Conference:
Longdom Conferences has previously provided an international platform for researchers, clinicians, academicians, healthcare professionals, students, and industry representatives to exchange knowledge and discuss developments in hematology and blood disorders.
Previous scientific discussions have covered areas including hematologic malignancies, thrombosis and hemostasis, sickle cell disease, leukemia, gene therapy, hemophilia, platelet disorders, lymphoma, hematopoiesis, red blood cell disorders, and emerging therapeutic approaches.
The conferences have provided opportunities for participants to present research findings, engage in scientific discussions, establish professional connections, and explore collaborations across hematology and related healthcare disciplines.
Building on these scientific discussions, Longdom Conferences continues to provide a global platform for exploring emerging discoveries, innovative therapies, advanced diagnostics, and future directions in Hematology and Blood Disorders.

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Newsletter

About

Hematology and Blood Disorders